News from amerigen pharmaceuticals A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Sep 23, 2019, 09:37 ET Amerigen to Commercialize Two of Inventia's ANDA's

Amerigen Pharmaceuticals Limited ("Amerigen") and Inventia Healthcare Limited ("Inventia") today announced they had entered into a collaboration...


May 08, 2019, 15:34 ET Amerigen Announces U.S. FDA Approval For Generic Penicillamine 250 mg Capsules

Amerigen Pharmaceuticals Limited ("Amerigen") today announced that Amerigen's Abbreviated New Drug Application ("ANDA") for Penicillamine Capsules...


Jan 24, 2019, 09:01 ET Amerigen Announces U.S. FDA Approval For Generic Mixed Amphetamine Salts, Extended-Release Capsules

Amerigen Pharmaceuticals Limited ("Amerigen") today announced that its Abbreviated New Drug Application ("ANDA") for a generic version of Shire's...


Jun 07, 2018, 10:24 ET Amerigen Launches Generic Bexarotene Capsules

Amerigen Pharmaceuticals Limited ("Amerigen") today announced the commercial launch of its generic bexarotene 75mg capsules following the recent...


Apr 23, 2018, 08:52 ET Amerigen and Dipharma Announce U.S. FDA Approval for Generic Miglustat 100 mg Capsules

Amerigen Pharmaceuticals Limited ("Amerigen") and Dipharma S.A. ("Dipharma") today announced that Amerigen's Abbreviated New Drug Application...


Mar 20, 2018, 01:50 ET Amerigen Pharmaceuticals Limited today announced that its Abbreviated New Drug Application for cyclophosphamide capsules 25mg and 50mg has received final approval from the U.S. Food and Drug Administration

Amerigen Pharmaceuticals Limited ("Amerigen") today announced that its Abbreviated New Drug Application ("ANDA") for cyclophosphamide capsules 25mg...


Jan 18, 2018, 05:58 ET Amerigen's petition leads to U.S. Zytiga® patent invalidation

In relation to the recently announced decision by the Patent Trial and Appeal Board ("PTAB") on Amerigen Pharmaceuticals Limited's inter partes...


Oct 24, 2017, 09:37 ET Amerigen and Biophore Collaborate on Penicillamine Generics

Amerigen Pharmaceuticals Limited ("Amerigen") and Biophore India Pharmaceuticals Pvt Ltd. ("Biophore") today announced that they are collaborating to ...


Sep 05, 2017, 09:37 ET Amerigen believes that it is a first applicant to file an Abbreviated New Drug Application ("ANDA") for certain strengths of Namzaric® containing a "Paragraph IV" patent certification under the provisions of the Hatch-Waxman Act

Amerigen Pharmaceuticals Limited ("Amerigen") today announced that, based on the August 7th, 2017 update to the U.S. Food & Drug Administration's...


Aug 18, 2016, 10:53 ET AMERIGEN announces final approval from FDA for generic version of Temodar®

Amerigen Pharmaceuticals Limited ("Amerigen") today announced that the U.S. Food and Drug Administration (FDA) has granted final approval to the...


Aug 02, 2016, 09:37 ET AMERIGEN announces final approval from FDA for generic version of Lysteda®

Amerigen Pharmaceuticals Limited ("Amerigen") today announced that the U.S. Food and Drug Administration (FDA) has granted final approval to the...


Jan 12, 2016, 09:37 ET AMERIGEN and DIPHARMA announce first regulatory submission for Miglustat 100mg Capsules

Amerigen Pharmaceuticals Limited and Dipharma S.A. today announced that a regulatory submission of an Abbreviated New Drug Application for Miglustat...


Apr 30, 2015, 09:54 ET AMERIGEN Announces Tentative Approval of Generic Toviaz®

Amerigen Pharmaceuticals Limited today announced that the U.S. Food and Drug Administration (FDA) has granted tentative approval to the Company's...


Apr 17, 2015, 09:37 ET AMERIGEN Announces Tentative Approval of Generic Bystolic®

Amerigen Pharmaceuticals Limited today announced that the U.S. Food and Drug Administration (FDA) has granted tentative approval to the Company's...


Jan 09, 2015, 09:37 ET Fosun Pharma to invest in Amerigen Pharmaceuticals

Amerigen Pharmaceuticals Limited ("Amerigen") today announced the signing of an agreement with an affiliate of Fosun Pharma ("Fosun") under which...


Aug 20, 2014, 09:37 ET Amerigen Pharmaceuticals Ltd. announces that its Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., has received Chinese FDA (CFDA) approval and has subsequently launched its generic Mecobalamin 0.5 mg Tablets into the China domestic market

Amerigen Pharmaceuticals Ltd. announces that its Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., has received Chinese FDA (CFDA)...


Mar 12, 2014, 09:00 ET Amerigen Pharmaceuticals Limited announces that its ANDA for carbidopa 25mg tablets has received final approval from the U.S. Food and Drug Administration

Amerigen Pharmaceuticals Limited announces that its ANDA for carbidopa 25mg tablets has received final approval from the U.S. Food and Drug...


Jul 31, 2013, 09:37 ET Amerigen Pharmaceuticals Limited today announced it had entered into a collaboration agreement with Forest Laboratories Inc. regarding the development of a number of specialty generic products.

Amerigen Pharmaceuticals Limited today announced it had entered into a collaboration agreement with Forest Laboratories Inc. regarding the...


Mar 15, 2012, 02:16 ET Amerigen Announces ANDA Filing and BYSTOLIC® Patent Challenge

Amerigen Pharmaceuticals Limited today confirmed that its subsidiary Amerigen Pharmaceuticals Inc. has filed an Abbreviated New Drug Application...


Jan 05, 2012, 02:06 ET Amerigen Pharmaceuticals President and CEO to Present a Company Overview at the J.P. Morgan Healthcare Conference

Amerigen Pharmaceuticals announced today that John Lowry, Amerigen's President & CEO, will present an overview of the company at the 30th Annual J.P. ...


Jun 08, 2011, 09:37 ET Amerigen Pharmaceuticals and AustarPharma Enter Into Collaboration Agreement for Generic Oral Controlled Release Products

Amerigen Pharmaceuticals Limited and AustarPharma, LLC today announced they had entered into a broad-based collaboration agreement regarding the...